ZUCLOPENTHIXOL, D-1 D-2 ANTAGONIST, FOR TREATMENT OF CHRONIC AGGRESSIVE SCHIZOPHRENIA AND PSYCHOTIC OLIGOPHRENIC PATIENTS/

Authors
GRINSHPOON A MOSKOWITZ M VALEVSKI A KREIZMAN A PALEI L MARK M WEIZMAN A
Citation
A. Grinshpoon et al., ZUCLOPENTHIXOL, D-1 D-2 ANTAGONIST, FOR TREATMENT OF CHRONIC AGGRESSIVE SCHIZOPHRENIA AND PSYCHOTIC OLIGOPHRENIC PATIENTS/, European psychiatry, 13(5), 1998, pp. 273-275
Citations number
10
Categorie Soggetti
Psychiatry
Journal title
European psychiatry → ACNP
ISSN journal
09249338
Volume
13
Issue
5
Year of publication
1998
Pages
273 - 275
Database
ISI
SICI code
0924-9338(1998)13:5<273:ZDDAFT>2.0.ZU;2-U
Abstract
An open label trial was conducted to study the efficacy of zuclopenthi xol decanoate, a D-1/D-2 antagonist, in the treatment of chronic (> 10 years) neuroleptic-resistant aggressive schizophrenia (n = 10) and ps ychotic oligophrenic patients (n = 6). A significant reduction was not ed in the Brief Psychiatric Rating Scale score, especially in the clus ters of hostility-suspiciousness and excitement. After many years of s eclusion, ten of the 16 patients were transferred to an open psychiatr ic department and were allowed to visit their families. (C) 1998 Elsev ier, Paris.